Skip to content

The Effects of Strawberries on Blood Pressure in Postmenopausal Women

Daily Incorporation of Strawberries Into a Diet Favorably Improves Vascular Function and Lowers Aortic Blood Pressure in Postmenopausal Women With Prehypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02099578
Enrollment
60
Registered
2014-03-31
Start date
2013-02-28
Completion date
2014-07-31
Last updated
2016-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Hypertension, Vascular Diseases

Keywords

Blood pressure, Arterial stiffness, Pulse wave velocity, Strawberries, Endothelial function, Oxidative stress, Postmenopausal women

Brief summary

Cardiovascular disease (CVD) is the leading cause of death in the US. Statistics show that approximately 91% of individuals with CVD have vascular dysfunction. Hypertension is a major modifiable risk factor for CVD and approximately 60% of adults in the US are pre-hypertensive and hypertensive. In addition, the prevalence of hypertension is associated with aging in both genders; however, the increase in blood pressure (BP) in women after menopause exceeds that of men. The development of effective and safe strategies to improve vascular function is of significance as it can have a great impact on quality of life, productivity and economic burden for the affected populations. One such alternative would be to introduce into the diet food sources that are rich in naturally occurring bioactive compounds. Thus, the long-term goal of the investigators is to provide feasible and effective dietary ways for postmenopausal women to improve their vascular function and quality of life. Strawberries are a rich source of bioactive compounds and its total antioxidant content ranks third among all fruits and vegetables. Hence, the purpose of this study is to bring forth evidence that incorporation of strawberries into the diet will reduce blood pressure and improve cardiovascular function in pre- and stage 1-hypertensive postmenopausal women. Sixty eligible postmenopausal women between the ages of 45 and 65 and a seated BP of ≥ 130/85 mm Hg but ≤ 160/100 mmHg at the screening visit will be randomly assigned to one of three groups: 1. 25 g freeze-dried strawberry powder; 2. 50 g freeze-dried strawberry powder; or 3. placebo powder. Participants will be asked to consume the supplements for 8-weeks. Medical history, medication use, dietary intake, and physical activity will be assessed at 0-, 4-, and 8-weeks followed by blood draw. Serum levels of markers of cardiovascular function as well as oxidative stress and inflammation will be measured. The investigators hypothesize that regular consumption of strawberry will improve cardiovascular function, decrease BP and blood markers of oxidative stress as well as inflammation. Investigators also expect the findings of this study to provide a foundation for further studies to examine the effects of long-term incorporation of strawberry into the diet and the integrity of cardiovascular system.

Interventions

DIETARY_SUPPLEMENT25 g of Freeze-dried Strawberry Powder

Participants will be given one packet of 25 g of freeze-dried strawberry powder and one packet of 25 g of placebo powder and asked to consume one packet in the morning and one at night.

DIETARY_SUPPLEMENT50 g of Freeze-dried Strawberry Powder

Participants will be given two packets of 25 g of freeze-dried strawberry powder and asked to consume one packet in the morning and one at night.

DIETARY_SUPPLEMENTPlacebo Powder

Participants will be given two packets of 25 g of placebo powder and asked to consume one packet in the morning and one at night.

Sponsors

California Strawberry Commission
CollaboratorOTHER
Florida State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Postmenopausal women (1 to 10 years after natural menopause or bilateral oophorectomy) * 45-65 years of age * Seated blood pressure ≥ 130/85 mm Hg but ≤ 160/100 mm Hg * BMI \> 25 but \< 40 kg/m2

Exclusion criteria

* Seated blood pressure ≤ 129/84 or ≥160/101 mmHg * Type I Diabetes * Cardiovascular disease * Active cancer * Glaucoma * Thyroid disease * Kidney disease * Liver disease * Pancreatic disease * Enrollment in a weight loss program * Heavy smokers (\>20 cigarettes per day)

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure8 weeksBy measuring blood pressure variability and baroreflex sensitivity at rest and during physiological stress (handgrip exercise and post-exercise muscle ischemia).

Secondary

MeasureTime frameDescription
Arterial Stiffness8 weeksBy assessing pulse wave velocity and augmentation index at rest and during physiological stress (handgrip exercise and post-exercise muscle ischemia).
Endothelial function8 weeksBy assessing blood biomarkers of vascular function (adiponectin, leptin, endothelin-1, angiotensin II and 8-isoprostane).
Oxidative Stress8 weeksBy assessing blood biomarkers of oxidative stress (superoxide dismutase, nitrate/nitrite, 8-isoprostane, malondialdehyde , and oxidized low density lipoprotein).
Inflammation8 weeksBy assessing blood biomarkers of inflammation (tumor necrosis factor-α and C-reactive protein).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026